Who We Are
Magee-Womens Research Institute (MWRI) is the largest research institute in the U.S. devoted exclusively to women’s health research.
MWRI is making discoveries and advancing knowledge in many areas affecting women including: reproductive biology, breast cancer genomics and personalized therapies, HIV immunization and prevention, fertility preservation, and is a recognized leader in clinical pelvic floor research. Through our revolutionary 9-90™ research, we focus on how pregnancy and fetal development can affect population health for future generations. We firmly believe that new insights into the role of early human development in defining short- and long-term health and wellness will transform our understanding of disease development, treatment and prevention for future generations.
Be the world leader in women’s health and reproductive sciences so that our discoveries make dramatic positive impact on the health and future of humankind.
Our mission is to change the world’s thinking on women’s health, and its investment in women’s health research; to firmly establish MWRI as a global research leader; to expand our worldwide collaborative research network; and to accelerate the translation of that research into practice and improved clinical outcomes.
In 1990, Irma Goertzen, then CEO of Magee-Womens Hospital, launched research initiatives in women’s health that would give rise to what is now the prestigious Magee-Womens Research Institute. Since its inception, Magee has brought more than $400 million in project funding to Pittsburgh from the National Institutes of Health (NIH) and other sources. Today, Magee-Womens Research Institute and Magee-Womens Hospital of UPMC are home to more than 100 faculty members who collaborate with dozens of affiliate researchers located through the University of Pittsburgh and Carnegie Mellon campuses.